S. E. Sephton, R. M. Sapolsky, H. C. Kraemer and D. Spiegel, “Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival,” Journal of the National Cancer Institute, Vol. 92, No. 12, 2000, pp. 994-1000. doi:10.1093/jnci/92.12.994
 K. Yokoyama, S. Araki, J. Osuga, T. Karita, M. Kurokawa and K. Koda, “Production of the Japanese Edition of Profile of Mood States (POMS): Assessment of Reliability and Validity,” Japanese Journal of Public Health, Vol. 37, 1990, pp. 913-918 (In Japanese).
 S. Morita, K. Kobayashi, K. Eguchi, T. Matsumoto, M. Shibuya, Y. Yamaji, J. Sakamoto and Y. Ohashi, “Influence of Clinical Parameters on Quality of Life During Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Application of a General Linear Model,” Japanese Journal of Clinical Oncology, Vol. 33, No. 9, 2003, pp. 470-476. doi:10.1093/jjco/hyg083
 D. F. Cella, D. S. Tulsky, G. Gray, B. Sarafian, E. Linn, A. Bonomi, M. Silberman, S. B. Yellen, P. Winicour, J. Brannon and F. David, “The Functional Assessment of Cancer Therapy Scale Development and Validation of the General Measure,” Journal of Clinical Oncology, Vol. 11, No. 3, 1993, pp. 570-579.
 A. Yoshimura, K. Kobayashi, H. Fumimoto, Y. Fujiki, S. Eremenco and S. H. Kudoh, “Cross-Cultural Validation of an International Questionnaire, the General Measure of the Functional Assessment of Cancer Therapy Scale (FACT-G), for Japanese,” Quality of Life Research, Vol. 10, No. 8, 2001, pp. 701-709. doi:10.1023/A:1013851216181
 D. F. Cella, A. E. Bonomi, S. R. Lloyd, D. S. Tulsky, E. Kaplan and P. Bonomi, “Reliability and Validity of the Functional Assessment of Cancer Therapy—Lung (FACTL) Quality of Life Instrument,” Lung Cancer, Vol. 12, No. 3, 1995, pp. 199-220. doi:10.1016/0169-5002(95)00450-F
 E. Saitoh, Y. Yokomizo, C. H. Chang, S. Eremenco, H. Kaneko and K. Kobayashi, “Cross-Cultural Validation of the Japanese Version of the Lung Cancer Subscale on the Functional Assessment of Cancer Therapy-Lung,” Journal of Nippon Medical School, Vol. 74, No. 6, 2007, pp. 402-408. doi:10.1272/jnms.74.402
 M. Biondi and A. Picardi, “Psychological Stress and Neuroendocrine Function in Humans: The Last Two Decades of Research,” Psychotherapy and Psychosomatics, Vol. 68, No. 3, 1999, pp. 114-150. doi:10.1159/000012323
 C. Kirschbaum and D. H. Hellhammer, “Salivary Cortisol in Psychoneuroendocrine Research: Recent Developments and Applications,” Psychoneuroendocrinology, Vol. 19, No. 4, 1994, pp. 313-333. doi:10.1016/0306-4530(94)90013-2
 Y. Noto, T. Sato, M. Kudo, K. Kurata and K. Hirota, “The Relationship between Salivary Biomarkers and State-Trait Anxiety Inventory Score under Mental Arithmetic Stress: A Pilot Study,” Anesthesia & Analgesia, Vol. 101, No. 6, 2005, pp. 1873-1876. doi:10.1213/01.ANE.0000184196.60838.8D
 D. Kajdaniuk, B. Marek, E. Swietochowska, N. Ciesielska-Kopacz and B. Buntner, “Is Positive Correlation between Cortisol and Met-Enkephalin Concentration in Blood of Women with Breast Cancer a Reaction to Stress before Chemotherapy Administration?” Pathophysiology, Vol. 7, No. 1, 2000, pp. 47-51. doi:10.1016/S0928-4680(00)00028-6
 M. H. Lasikiewicz, H. Hendrickx, D. Talbot and L. Dye, “Exploration of Basal Diurnal Salivary Cortisol Profiles in Middle-Aged Adults: Associations with Sleep Quality and Metabolic Parameters,” Psychoneuroendocrinology, Vol. 33, No. 2, 2008, pp. 143-151. doi:10.1016/j.psyneuen.2007.10.013
 J. M. Turner-Cobb, S. E. Sephton, C. Koopman, J. BlakeMortimer, D. Spiegel, “Social Support and Salivary Cortisol in Women with Metastatic Breast Cancer,” Psychosomatic Medicine, Vol. 62, No. 3, 2000, pp. 337-345.